The landscape of dementia prognosis has evolved dramatically with the arrival of subtle biomarkers, like amyloid PET scans, tau imaging, and blood-centered tests that could detect Alzheimer's pathology years just before signs or symptoms emerge. Although these technological advancements represent exceptional development in being familiar with neuro